IL-37 is a fundamental inhibitor of innate immunity - Wikidata - awgldk - TriplyDB

IL-37 is a fundamental inhibitor of innate immunity

IL-37 is a fundamental inhibitor of innate immunity

http://www.wikidata.org/entity/Q28295265

about

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer Interactions between Autophagy and Inhibitory Cytokines Regulatory Role of IL-1R8 in Immunity and Disease The IL-1 cytokine family and its role in inflammation and fibrosis in the lung Interleukin-1 Family Cytokines in Liver Diseases Immunology of hepatocellular carcinoma From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines Anti-Inflammatory and Antimicrobial Actions of Vitamin D in Combating TB/HIV Clinical biomarkers and pathogenic-related cytokines in rheumatoid arthritis Periodic Exposure of Keratinocytes to Cold Physical Plasma: An In Vitro Model for Redox-Related Diseases of the Skin.Cytokines in psoriasis IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors Epithelial expression of interleukin-37b in inflammatory bowel disease Systematic identification and characterization of novel human skin-associated genes encoding membrane and secreted proteins Plasma levels of IL-37 and correlation with TNF-α, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis The Role of IL-37 in Non-Cancerous Diseases.The role of IL-37 in cancer.Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia.IL-32 promotes angiogenesis.Refining anti-inflammatory therapy strategies for bronchopulmonary dysplasia.Circulating tumor cells promote the metastatic colonization of disseminated carcinoma cells by inducing systemic inflammation Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells.Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms Elevated IL-37 levels in the plasma of patients with severe coronary artery calcification Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.Caspase-1: an integral regulator of innate immunity.Anti-inflammatory effect of IL-37b in children with allergic rhinitis.The possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease.IL-1 family nomenclature.Differential expression of interleukin-1/Toll-like receptor signaling regulators in microscopic and ulcerative colitis.Increased expression of IL-37 in patients with Graves' disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells.IL-27 Regulates IL-18 binding protein in skin resident cells The interleukin-1 family: back to the future Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells.Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β.[Caspase-1 regulates autoinflammation in rheumatic diseases].Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular function

P2860

Q24606766-D3F2A696-A37D-4445-9AF0-BC44246CBB25 Q26738539-92A77DEB-C72D-4671-A9C6-38CE41EE6813 Q26745577-0BE5D456-5CDC-4DB6-8468-FBF9A3D66059 Q26752524-66AEE07B-0FB1-44F4-8996-811F2B0DA7CF Q26752849-E0C7A79E-C5B8-4B18-8075-6440E36DB1B5 Q26778553-E01F2B2E-1FC6-40E9-BAF6-6C941E38BAAA Q26795411-D3DD5BDD-DBAF-42F3-B7B7-710F85933BAE Q27008912-A3292B22-4C20-4C44-9DDB-F19D434E68EA Q27011921-CB3A89D2-2295-4527-9664-EAFAB0695CB2 Q27022559-C5B5990C-CAD8-4206-8094-EAB7EA01D43D Q27348706-7641837E-3F89-4DE3-B41E-190862093E2D Q28255491-6C8C6014-8D5A-499E-9850-C1B519CF6C5A Q28258076-0C9F64AD-DA34-4799-A649-FA6C637F9B83 Q28395194-EB0233FB-D799-48DD-B89A-DCB1B4A23AC0 Q28397770-8D407F5B-F802-47C4-A09F-372633CA6DB9 Q28534046-8F481677-9AFD-4AA0-B6CD-74854233B895 Q28538381-5F399061-24FF-40AD-8202-3BCA85F1FD07 Q28544789-9F5CB5AA-6DAE-4E92-B1E2-686E447F585D Q30152709-D6CB34CB-9318-404C-B720-5D57E0EB66C6 Q30152777-0465E153-1B0D-47D8-8C6E-9666A94728F2 Q30544045-0213E2B9-EB52-4640-BDCB-1CA84DD0C572 Q33555523-FA4AE5D3-16BB-48D4-99DA-66786E75201A Q33684200-EE99E0D4-FAA6-4F44-8C35-D406AD719CEB Q33709719-AA10A404-EBE3-4A63-9352-0D651F0F897D Q33713444-A7F828BC-4881-434B-9E4E-ED8DF66E84BE Q33756712-0E45F9D7-1F2D-4106-8860-ECC25C8426C5 Q33785539-52F852AF-D35B-42E4-BBBE-78572ACBA166 Q33801215-EA31FA09-D422-4E3B-9138-3128B733CBB3 Q34044187-CFB43C9E-9B16-4DC1-8F8D-60DB08B2C5FA Q34081822-B2983847-2085-4199-9C0C-351F7B4203D8 Q34119277-FC327188-B6E1-42D2-B693-0D96B05FD440 Q34144622-65058EFD-EFCC-488B-A9FB-C1B044505860 Q34168594-DA197E82-ED61-4E8B-ABB2-203922C830B1 Q34196219-E75EC581-5F58-4008-80E7-7969C1EBDF27 Q34325776-4D7CB315-B8FF-4FDA-A69F-71E8CE5FFF8E Q34391415-80C1F73C-7157-42C7-A363-438BE6CFA090 Q34408962-BE3CE3F6-129D-4B53-942B-2CEB39C19CBB Q34504994-628628C8-D69B-4BAD-A43E-CE9C9AD9B95A Q34520488-ECE01F62-0580-44BB-9729-AC1A612ECEE3 Q34538722-0D52BC46-E01D-4A5A-B08C-D186B7C8209C

P2860

IL-37 is a fundamental inhibitor of innate immunity

http://www.wikidata.org/entity/Q28295265

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

IL-37 is a fundamental inhibitor of innate immunity

@ast

IL-37 is a fundamental inhibitor of innate immunity

@en

IL-37 is a fundamental inhibitor of innate immunity

@nl

type

label

IL-37 is a fundamental inhibitor of innate immunity

@ast

IL-37 is a fundamental inhibitor of innate immunity

@en

IL-37 is a fundamental inhibitor of innate immunity

@nl

prefLabel

IL-37 is a fundamental inhibitor of innate immunity

@ast

IL-37 is a fundamental inhibitor of innate immunity

@en

IL-37 is a fundamental inhibitor of innate immunity

@nl

P1433

Q28295265-24084C43-0AE0-4F18-B412-146023CB3B9A

P1476

Q28295265-54D15012-333A-49E3-BC48-EE6A980ADB8B

P2093

Q28295265-526720D8-01D3-4504-87A8-F6ED02EABED1

Q28295265-61F01D0C-9DD2-42A5-A028-A52A4D1049B8

Q28295265-7025D020-8563-4778-9371-B8B9CCD33012

Q28295265-B239039B-879B-4406-8A3A-C632188D01CB

P2860

Q28295265-045645B7-7C66-4557-9985-00D5EF1716AA

Q28295265-0719AACB-0094-4266-B98C-EEFF802C7F62

Q28295265-0FE3763B-A8E8-4BC0-89DF-DF24FF7322EF

Q28295265-1EF03DB9-4435-48BA-9DE6-4C0C737C822D

Q28295265-23A4C92E-1533-42A6-AEBA-F8C24D3B855A

Q28295265-247AC3F2-EE69-4523-A73A-19675AE39631

Q28295265-28CF7FDD-A853-4345-8186-AE98A5755092

Q28295265-295AF9E1-3145-4E7F-91FD-13D9FA1751D1

Q28295265-2B919BB6-7690-47A1-A343-352DEAE46A03

Q28295265-2C75B5FB-AAD5-4DA9-862B-45FC3C42B7DC

P304

Q28295265-75C346F3-7068-4B26-9549-DA6392BD5C49

P31

Q28295265-B4C9F352-8DBE-479B-919F-307A11EF10A3

P3181

Q28295265-1C901B98-4ED0-412B-B933-1856E25D4921

P356

Q28295265-6B53F6A1-3EEB-4ED7-956D-60FAC4E00C7C

P407

Q28295265-EB4FA364-0666-473D-B3BE-5EEFFA1DA51C

P433

Q28295265-1D659668-025B-4C23-A6C0-8C4F016D0BF7

P478

Q28295265-57326398-AF4A-4D65-8FD7-623ED3AFADB4

P50

Q28295265-09DCF0C7-FFE8-4110-BCD7-875236253D34

Q28295265-53882403-21FA-429F-8EF7-66F7C8F4DD05

Q28295265-FE48D11A-8310-428F-B33C-CFD28B2F0492

P577

Q28295265-CE62FB84-DF9A-4D0E-9A72-AB7B69A780D9

P5875

Q28295265-9FEE2D8D-DA20-4445-80C8-0EACADC5B9D0

P698

Q28295265-5426F013-4F14-4AAA-B6F0-6C1C95C4E23C

P932

Q28295265-8F4D0A08-B14B-4220-842E-E84677AC162E

P3181

P356

P1433

Nature Immunology

P1476

IL-37 is a fundamental inhibitor of innate immunity

@en

P2093

Brent E Palmer

http://www.w3.org/2001/XMLSchema#string

Charles A Dinarello

http://www.w3.org/2001/XMLSchema#string

Claudia A Nold-Petry

http://www.w3.org/2001/XMLSchema#string

Jarod A Zepp

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response

Four new members expand the interleukin-1 superfamily

Identification and initial characterization of four novel members of the interleukin-1 family

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity.

Crystallographic refinement of interleukin 1 beta at 2.0 A resolution

Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation

Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1

Identification and gene organization of three novel members of the IL-1 family on human chromosome 2

IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp

P304

1014-1022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

378585

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NI.1944

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47384805

http://www.w3.org/2001/XMLSchema#string

P698

20935647

http://www.w3.org/2001/XMLSchema#string

P932

3537119

http://www.w3.org/2001/XMLSchema#string